Stem cell therapies for spinal cord injury

被引:177
作者
Sahni, Vibhu [2 ]
Kessler, John A. [1 ]
机构
[1] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Harvard Univ, Sch Med, MGH HMS Ctr Nervous Syst Repair, Boston, MA 02114 USA
关键词
CHONDROITIN SULFATE PROTEOGLYCAN; FIBRILLARY ACIDIC PROTEIN; MESENCHYMAL STROMAL CELLS; AXONAL REGENERATION; FUNCTIONAL RECOVERY; CLINICAL-TRIALS; ICCP PANEL; DIRECTED DIFFERENTIATION; RESTRICTED PRECURSORS; TYROSINE-PHOSPHATASE;
D O I
10.1038/nrneurol.2010.73
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Stem cell therapy is a potential treatment for spinal cord injury (SCI), and a variety of different stem cell types have been evaluated in animal models and humans with SCI. No consensus exists regarding the type of stem cell, if any, that will prove to be effective therapeutically. Most data suggest that no single therapy will be sufficient to overcome all the biological complications caused by SCI. Rationales for therapeutic use of stem cells for SCI include replacement of damaged neurons and glial cells, secretion of trophic factors, regulation of gliosis and scar formation, prevention of cyst formation, and enhancement of axon elongation. Most therapeutic approaches that use stem cells involve implantation of these cells into the spinal cord. The attendant risks of stem cell therapy for SCI-including tumor formation, or abnormal circuit formation leading to dysfunction-must be weighed against the potential benefits of this approach. This Review will examine the biological effects of SCI, the opportunities for stem cell treatment, and the types of stem cells that might be used therapeutically. The limited information available on the possible benefits of stem cell therapy to humans will also be discussed.
引用
收藏
页码:363 / 372
页数:10
相关论文
共 129 条
[1]   A global perspective on spinal cord injury epidemiology [J].
Ackery, A ;
Tator, C ;
Krassioukov, A .
JOURNAL OF NEUROTRAUMA, 2004, 21 (10) :1355-1370
[2]   Geron gets green light for human trial of ES cell-derived product [J].
Alper, Joe .
NATURE BIOTECHNOLOGY, 2009, 27 (03) :213-214
[3]   FETAL NEURAL GRAFTS AND REPAIR OF THE INJURED SPINAL-CORD [J].
ANDERSON, DK ;
HOWLAND, DR ;
REIER, PJ .
BRAIN PATHOLOGY, 1995, 5 (04) :451-457
[4]  
[Anonymous], 2010, PAR FACTS FIG
[6]   Stem cells for spinal cord repair [J].
Barnabe-Heider, Fanie ;
Frisen, Jonas .
CELL STEM CELL, 2008, 3 (01) :16-24
[7]   Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection [J].
Basso, DM ;
Beattie, MS ;
Bresnahan, JC .
EXPERIMENTAL NEUROLOGY, 1996, 139 (02) :244-256
[8]   ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury [J].
Beattie, MS ;
Harrington, AW ;
Lee, R ;
Kim, JY ;
Boyce, SL ;
Longo, FM ;
Bresnahan, JC ;
Hempstead, BL ;
Yoon, SO .
NEURON, 2002, 36 (03) :375-386
[9]   Position statement on the sale of unproven cellular therapies for spinal cord injury The International Campaign for Cures of Spinal Cord Injury Paralysis [J].
Blight, A. ;
Curt, A. ;
Ditunno, J. F. ;
Dobkin, B. ;
Ellaway, P. ;
Fawcett, J. ;
Fehlings, M. ;
Grossman, R. G. ;
Lammertse, D. P. ;
Privat, A. ;
Steeves, J. ;
Tuszynski, M. ;
Kalichman, M. ;
Guest, J. D. .
SPINAL CORD, 2009, 47 (09) :713-714
[10]  
BLIGHT AR, 1992, J NEUROTRAUM, V9, pS83